Vaccine development against schistosomiasis from concepts to clinical trials

Authors: André Capron¹; Monique Capron¹; Gilles Riveau¹

Source: British Medical Bulletin, Volume 62, Number 1, July 2002 , pp. 139-148(10)

Publisher: Oxford University Press

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Schistosomiasis is still a major helminth infection at the beginning of the 21st century and an important public health problem in many non-industrialised countries. As the second major parasitic disease in the world after malaria, schistosomiasis affects 200 million people, 800 million being exposed to the risk of infection. It is also estimated that 20 million individuals suffer from severe consequences of this chronic and debilitating disease responsible for at least 500,000 deaths per year.

Document Type: Research article

Affiliations: 1: INSERM U 547, Institut Pasteur de Lille, Lille, France

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.19 plus tax Refund Policy